Nomura Holdings Inc Abb Vie Inc. Put Options Transaction History

Nomura Holdings Inc

$41.1 Billion
Q3 2024

Put Options

14 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$163.84 - $199.33 $7.77 Million - $9.45 Million	47,400 Added 316.0%	62,400 $12.3 Million
Q1 2024 May 15, 2024	BUY	$159.82 - $182.1 $2.4 Million - $2.73 Million	15,000 New	15,000 $2.73 Million
Q4 2023 Feb 14, 2024	SELL	$137.6 - $154.97 $2.05 Million - $2.31 Million	-14,900 Reduced 59.6%	10,100 $1.57 Million
Q2 2023 Aug 14, 2023	SELL	$132.51 - $164.9 $4.33 Million - $5.39 Million	-32,700 Reduced 56.67%	25,000 $3.37 Million
Q1 2023 May 15, 2023	BUY	$144.61 - $166.54 $8.34 Million - $9.61 Million	57,700 New	57,700 $9.2 Million
Q2 2022 Aug 15, 2022	SELL	$137.62 - $174.96 $13.8 Million - $17.5 Million	-100,000 Reduced 66.67%	50,000 $7.69 Million
Q4 2021 Feb 14, 2022	SELL	$107.43 - $135.93 $3.61 Million - $4.57 Million	-33,610 Reduced 18.31%	150,000 $20.3 Million
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $10.9 Million - $14.5 Million	147,910 Added 414.31%	183,610 $18 Million
Q1 2020 May 14, 2020	SELL	$64.5 - $97.79 $6.67 Million - $10.1 Million	-103,400 Reduced 74.34%	35,700 $2.72 Million
Q3 2019 Nov 14, 2019	BUY	$62.98 - $75.72 $6.02 Million - $7.24 Million	95,600 Added 219.77%	139,100 $10.2 Million
Q1 2018 May 14, 2018	SELL	$92.01 - $123.21 $18.1 Million - $24.3 Million	-197,000 Reduced 81.91%	43,500 $4.12 Million
Q1 2018 May 14, 2018	BUY	$92.01 - $123.21 $4 Million - $5.36 Million	43,500 Added 22.08%	240,500 $26.3 Million
Q4 2017 Feb 14, 2018	BUY	$89.56 - $98.21 $3.67 Million - $4.03 Million	41,000 Added 26.28%	197,000 $22.2 Million
Q3 2017 Nov 14, 2017	BUY	$69.85 - $89.22 $10.9 Million - $13.9 Million	156,000	156,000 $13.9 Million

Others Institutions Holding ABBV

# of Institutions

3,817

Shares Held

1.25B

Call Options Held

13M

Put Options Held

10M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $301B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Holdings Inc with notifications on news.

Account